Michael D. Shaw is a biochemist and freelance writer. A graduate of the University of California, Los Angeles, and a protégé of the late Willard Libby, winner of the 1960 Nobel Prize in chemistry, Shaw also did postgraduate work at the Massachusetts Institute of Technology. Based in Virginia, he covers technology, health care and entrepreneurship, among other topics.
Astronauts sometimes face the gravest threats after they return to Earth. Facing depression, alcoholism ...
North America has been ravaged by the opioid crisis ...
Not unlike the push to legalize marijuana for medical and recreational use, advocates say psychedelic mushrooms and plants—including cacti, Iboga …
For opioid addicts, African psychedelic ibogaine is last-resort detox drug. … Iboga is a shrub that is typically found in the Congo Basin in the Central …
Thomas Kingsley Brown, Ph.D., started his research on ibogaine treatment in November of 2009 when he conducted interviews with patients at Pangea Biomedics (then in Playas de Tijuana, Mexico) and collected data to study changes in Quality of Life for those patients. Hearing about the transformative experiences of these people convinced him that ibogaine’s therapeutic value merited further study. Since 2010 he has been working with the Multidisciplinary Association ...